Tapewire

OTC · USD

CTRVP

Hepion Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
8208
SEC CIK
0001583771
Parsed reports
99

Last 12 months

Inside the activity.

12 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202650
May 202600
Jun 202600
Jul 202600
Aug 202660
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 27, 2016 Filed Oct 31, 2016 17:39 UTC
SAPIRSTEIN JAMESDirector · Chief Executive Officer
Exercise / conversionStock Options · Derivative 16,666 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001104659-16-153407 · a4.xml · derivative · entry 2

SAPIRSTEIN JAMES · CIK 0001559509 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,133,334

Underlying: Common Stock · 16,666 shares

Expires 2026-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Fully vested.

Read SEC document
October 27, 2016 Filed Oct 31, 2016 17:39 UTC
SAPIRSTEIN JAMESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 16,666 $1.50 $24,999.00
Disclosure

SEC source: 0001104659-16-153407 · a4.xml · nonDerivative · entry 1

SAPIRSTEIN JAMES · CIK 0001559509 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.